Healthy volunteers test new immune globulin injection for tolerability
NCT ID NCT06935266
First seen Nov 03, 2025 · Last updated Apr 29, 2026 · Updated 27 times
Summary
This study tested how well healthy adults tolerate a new immune globulin injection called TAK-881. Sixty-four participants received one or more doses under the skin, with some getting a gradual ramp-up and others not. The goal was to see if the infusion could be completed without interruption due to side effects. The study lasted about 19 weeks and is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.